Deck the halls with res­ig­na­tions: Lian­Bio CEO, CFO out; CRISPR Ther­a­peu­tics CMO to leave in Jan­u­ary

→ On Dec. 16, Yizhe Wang turned in his res­ig­na­tion as CEO of Lian­Bio, while board mem­ber and Per­cep­tive chief in­vest­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.